Effective treatment of experimental models of androgen-sensitive and androgen-independent prostate cancer metastatic to the bone with targeted cytotoxic somatostatin analog AN-238. - Letsch,M.; Schally,AV.; Szepeshazi,K.; Halmos,G.; Nagy,A. (J Urol, 2004)